For instance, low doses of IL-18 were shown to accelerate tumor progression (66), in part through the induction of Kit+ immunosuppressive NK cells, while daily administration of IL-18 induced inflammation and increased the anti-tumor response, thus suppressing tumor growth. This evidence concerns the gene IL18 and neoplasm.